Feed PPBT
PP

Purple Biotech Ltd.

PPBT · NASDAQ

$1.44 -7.40% (-$0.12)
1M -7.69%
Market Cap $198.8K
P/E Ratio -
Div. Yield -
ROE 152.85%

Bulios Fair Price

$1.87

29.9% upside

Trenutna cena

$1.44

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica PPBT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
2/9
Valuation
100 /100
Cheap
P/B 0.02x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining
Book val. growth 40.84%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A
Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor
ROIC 62.43%
Asset turnover 0.00x
ROE 152.85%
Debt
69 /100
Low
Debt/Equity 0.01x
Int. coverage -3.82x
Current ratio 3.70x
Stability
19 /100
Unstable
Beta -0.53x
Profitable years 0
EPS volatility 14,444.23%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o PPBT
Online

O podjetju

Purple Biotech Ltd. (PPBT) is a biopharmaceutical company specializing in the development of drug products for the treatment of rare diseases and oncological conditions. The company focuses on researching and developing innovative therapeutic approaches that can improve the quality of life for patients with these serious diseases. Purple Biotech emphasizes the use of biotechnologies and new treatment methods with the potential to change the way diseases are treated. The company responds to the demand for new treatment options for rare diseases and oncological conditions. Shares of Purple Biotech Ltd. (PPBT) can be an interesting choice for investors tracking the biopharmaceutical and innovation sector.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

Gil Efron

Employees

10

Headquarters

Rehovot

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

53d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.